Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early Norepinephrine in Pediatric Septic Shock
NCT06461390Phase 3Completed
- Sponsor
- Universitas Indonesia
- Start
- Mar 2024
- Primary completion
- May 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of norepinephrine in septic shock (2 arms), sponsored by Universitas Indonesia. Primary endpoints: Stroke Volume Index, Cardiac Index and 1 more. Started Mar 2024; status: completed.
02
Drugs
norepinephrine
03
Conditions
septic shock
Beyond the preview
Go deeper on NCT06461390.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06461390.